ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.35
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
62,963.05
6.50%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Jazz Pharmaceuticals PLC (JAZZ)

  7. Jazz Pharmaceuticals PLC (JAZZ) 뉴스

JAZZ Jazz Pharmaceuticals PLC

110.01
0.72 (0.66%)
시간외 거래
최종 업데이트: 07:45:55
15분 지연
기업명 주식 심볼 시장 주식 타입
Jazz Pharmaceuticals PLC JAZZ 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.72 0.66% 110.01 07:45:55
개장가 저가 고가 종가 전일 종가
110.14 108.58 111.55 110.01 109.29
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202405:10PRNUSJazz Pharmaceuticals to Participate in the BofA Securities..
02/05/202405:05PRNUSJazz Pharmaceuticals Announces First Quarter 2024 Financial..
25/04/202405:05PRNUSJazz Pharmaceuticals to Present Data Across Growing Oncology..
18/04/202405:15PRNUSJazz Pharmaceuticals to Report 2024 First Quarter Financial..
10/04/202420:45PRNUSJazz Pharmaceuticals to Showcase Expansive Neuroscience..
02/04/202420:30PRNUSJazz Pharmaceuticals Completes Zanidatamab Biologics License..
13/03/202405:15PRNUSJazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on..
09/03/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202411:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202411:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202411:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202411:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202408:09EDGAR2Form 144 - Report of proposed sale of securities
06/03/202409:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/03/202405:11EDGAR2Form 144 - Report of proposed sale of securities
29/02/202406:06EDGAR2Form 8-K - Current report
29/02/202406:05PRNUSJazz Pharmaceuticals Announces Full Year and Fourth Quarter..
27/02/202421:45EDGAR2Form 8-K - Current report
27/02/202421:45PRNUSJazz Pharmaceuticals Appoints Patrick Kennedy to its Board..
21/02/202421:46EDGAR2Form 8-K - Current report
21/02/202421:45PRNUSJazz Pharmaceuticals Appoints Philip Johnson as Chief..
21/02/202406:15PRNUSJazz Pharmaceuticals to Participate in Upcoming March..
15/02/202406:15PRNUSJazz Pharmaceuticals to Report 2023 Full Year and Fourth..
07/02/202416:00PRNUSJazz Pharmaceuticals Enters Definitive Agreement with Redx..
26/01/202407:01EDGAR2Form 8-K - Current report
24/01/202423:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/01/202408:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202408:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202421:45EDGAR2Form 8-K - Current report
22/12/202306:05PRNUSJazz Pharmaceuticals Provides Update on Phase 2 Trial of..
21/12/202306:15PRNUSJazz Pharmaceuticals to Present at the 42nd Annual J.P...
15/12/202321:45EDGAR2Form 8-K - Current report
09/12/202303:20PRNUSJazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS..
07/12/202306:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202323:02PRNUSJazz Pharmaceuticals to Present Long-Term and Real-World..
30/11/202321:45PRNUSJazz Pharmaceuticals to Present New Data Highlighting..
14/11/202316:00BWAutifony Announces Exclusive Global License and..
09/11/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

최근 히스토리

NASDAQ
JAZZ
Jazz Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유